Russian President Vladimir Putin visited the western Kursk region on Tuesday, the first time he stopped by since Russian forces ejected Ukrainian troops from the area last month.During the visit, Putin met with volunteer organizations in the region and went to the Kursk-II nuclear power plant, according to the Kremlin.State TV showed the Russian president, accompanied by Kremlin first deputy chief of staff Sergei Kiriyenko, meeting volunteers and local officials in the region, including acting Gov. Alexander Khinshtein.US AWAITS CEASEFIRE PROPOSAL AFTER TRUMP PHONE CALL, RUBIO SAYSRussia said late last month that it had ejected Ukrainian forces from the Kursk region, putting an end to the biggest incursion into Russian territory since World War II.On Aug. 6, Ukraine carried out its boldest attack, pushing through the Russian border into the Kursk region, supported by swarms of drones and heavy Western weaponry.Ukrainian forces have claimed as much as about 540 square miles of Kursk.PRESIDENT TRUMP CONFIDENT PUTIN WANTS PEACE WITH UKRAINE, THINKS HE'S 'HAD ENOUGH' OF WARThis comes after Russian and Ukrainian officials met in Turkey last week for their first direct peace talks in years, but the two sides failed to reach a ceasefire agreement.The negotiations were the first face-to-face talks between the two countries since the early weeks of the war that began with a February 2022 invasion by Moscow.Reuters contributed to this report.

Since becoming secretary, I have been alarmed to find that our Army is at risk of falling behind other major powers across the globe, including China. Why? For decades, antiquated processes and bureaucratic bloat shackled our innovation and modernization efforts. If we continue business as usual our national security will be at risk. The gap between the Army we have and the Army we need is growing fast. Our soldiers are innovative, resourceful and capable they are our nations best. But they are being held back by lobbyists and complacent stakeholders who prioritized parochial interests over our soldiers lethality and readiness. No lobbyist ever took a hill. No lobbyist ever won a war. Our soldiers deserve better. And our nation deserves better. Thats why Secretary of Defense Pete Hegseth recently directed the Army to accelerate change. BILLIONS SPENT, WARFIGHTERS WAIT: INSIDE THE PENTAGONS BROKEN BUYING SYSTEM AND THE PLAN TO FIX ITWe got to work immediately.The Army Transformation Initiative (ATI) is how we break free from entrenched government bureaucracy, enable our soldiers and outpace our adversaries. This is the way forward:HEGSETH ORDERS SWEEPING ARMY OVERHAUL AND CONSOLIDATION AIMED AT COUNTERING CHINA AND GOLDEN DOME CAPABILITIESOur soldiers must out-survive and outfight the enemy on the battlefield. Today, they need drone and counter-drone capabilities, AI-driven decision-making and lethal, battle-ready tanks and attack aircraft. We have been slow to put these tools in our soldiers hands, not for lack of vision, but because of outdated acquisitions practices. That ends now. Our mission is clear: cut red tape so we can quickly equip troops with the best capabilities available.CLICK HERE FOR MORE FOX NEWS OPINIONWe will channel Americas bold and innovative spirit, not just in words, but in action. We will fuel market competition, back industry-led research and development, and streamline the process by placing users, testers and developers shoulder-to-shoulder in the field. We will embrace change and fight system inertia, keeping us agile, lethal and one step ahead of our enemies.For far too long, our hands have been tied by parochial interests propped up by swarms of lobbyists. We have been forced to buy gear that we no longer want or need. With ATI, well ensure that we use American taxpayers hard-earned dollars effectively. If a capability no longer benefits our soldiers and does not make our Army more lethal, we will not buy it. ARMY MAY SLASH 90,000 TROOPS AS PENTAGON FACES BUDGET CUTS AND STRATEGIC SHAKE-UP: REPORTWe are transforming the Army from the ground up, not just upgrading our processes and equipment. We are building an organization that will drive process improvements, leading to better products and better outcomes for soldiers. As a start, we will consolidate organizations within the Army to eliminate redundancies and reduce bureaucratic overhead. We will refocus resources on our fighting formations by cutting overhead, starting within the Army headquarters. We will get our soldiers back where they belong: training to dominate the battlefield and win wars. Our soldiers and the American people deserve an Army that is equipped to fight and win anywhere, anytime, against any adversary. Under the leadership of President Trump and Secretary Hegseth, thats exactly what the Army Transformation Initiative will deliver.

The political drama unfolding in America is a tale of missed opportunities, and the Democrats are the main characters struggling to find their footing. As Trumps polls falter, many wonder why the Dems arent capitalizing on the moment.Well, its no surprise to me. An ABC News-Washington Post-Ipsos poll released last month showed that 69% of people believe the Democratic Party is out of touch with most peoples concerns. Why? Because instead of focusing on peoples concerns, theyre stuck in the same tired routine: pointing fingers, highlighting Trumps faults, and decrying the chaos and threats to democracy. This strategy is fundamentally flawed.Recent events underscore this disconnect. Chaos at a detention facility in New Jersey highlights the ongoing immigration crisis, yet Democrats struggle to present a cohesive alternative. They could focus on pragmatic reforms, such as streamlining the asylum process, increasing border security with technology rather than walls, and creating pathways to citizenship for undocumented immigrants contributing to society.Meanwhile, internal conflicts within the party, like the fight over David Hogg's future inside the DNC, reveal a lack of unified vision. Instead of rallying around fresh voices and ideas, the party seems mired in internal disputes, further alienating potential supporters.DEMOCRATIC VOTERS SLAM THEIR OWN PARTY AS 'INEPT' AND 'USELESS' IN NY TIMES OPINION INTERVIEWAnd thats saying nothing about the alleged cover-up of former President Joe Bidens frail health highlighted in Jake Tapper and Alex Thompson's new book, "Original Sin" and the questions arising from his recent tragic prostate cancer diagnosis. All of this adds another layer of complexity. Instead of addressing these concerns head-on with transparency and a plan for continuity, the party seems to sidestep the issue, leaving voters with more questions than answers.All of this leads to a HUGE trust problem for the Democrats.Can they be trusted to tell the truth?Can they be trusted to solve our greatest problems?The answer is in plain view with Fox News' most recent survey where Democrats hit their lowest favorable rating ever, with only 41% viewing them positively.PRESIDENT TRUMP'S APPROVAL RATINGS SLIDE, BUT DEMOCRATS' POLL NUMBERS HITTING NEW LOWSThe drop in positivity toward the Democrats comes from within. Last summer, 87% of self-identified Democrats approved of their party, but thats now down to 77%. Meanwhile, the Republican Party saw a slight improvement among their party faithful, with 85% of self-identified Republicans holding a favorable view. The data is painting a very clear picture of the impact of the Democrats missteps.In 2017-2018, Democrats handled things much better. They had a clear narrative approaching the midterms: Trumps failure in his first term to deliver on healthcare was a tangible issue they could seize. They promised to mend what was brokenoffering plans like expanding the Affordable Care Act and reducing prescription drug prices. But now, instead of offering solutions, theyre fixated on Donald Trumps chaos and "evilness." The issue? Voters crave more than just a villain; they want a solution.CLICK HERE FOR MORE FOX NEWS OPINIONConsider the economy. While Democrats criticize Trumps trade wars and tax cuts for the wealthy, they often fail to articulate a clear economic vision of their own. Instead of merely opposing tariffs, they could propose comprehensive trade policies that protect American jobs while fostering global cooperation. Highlighting plans for infrastructure investment or green energy jobs, while not appealing to those on the right, could provide a positive, forward-looking agenda for many.Their rhetoric often spirals into extremescomparing Trump to Hitler or labeling his supporters as Nazis. While this may energize the base, it risks alienating moderates and undecided voters, or even everyday Americans who yearn for practical solutions over apocalyptic rhetoric. By framing the opponent as a boogeyman, they risk turning off the wider electorate.The bottom line is that Democrats need to pivot from a reactive, negative strategy to a proactive, solution-oriented approach if they want to win. They should focus on real policieshealthcare reform, economic growth, immigration reform, tariffswith clear plans to address these issues. Winning hearts and minds requires positive messaging, not just shouting about how bad Trump is. Otherwise, theyll continue to falter, running against an opponent who has mastered the narrative game and controls the conversation through chaos.To truly connect with voters, Democrats must offer a vision that resonates with their daily lives. By doing so, they could transform from the party of opposition to the party of solutions, but it doesnt seem like anyone is willing to step up to the plate to do just that.CLICK HERE TO READ MORE FROM LEE HARTLEY CARTER

Glioblastoma, the most aggressive and deadly type of brain cancer, is known to have a very poor prognosis but a new study suggests that a pain-relieving drug could extend survival.Researchers at Mass General Brigham have found that an already-approved medication a pain reliever and anti-seizure medication called gabapentin has been linked to improved survival in patients with glioblastoma.The findings were published in Nature Communications last week.MICHAEL BOLTON HAD STRANGE SYMPTOMS BEFORE BRAIN CANCER DIAGNOSIS: SOMETHINGS WRONGInspired by previous mouse studies that showed gadapentins potential in targeting tumors, the researchers studied the medical outcomes of nearly 700 patients with glioblastoma.Many of them had already been taking gabapentin to alleviate nerve pain, according to a press release from MGB.The patients who were taking the drug survived four months longer than those who were not 16 months compared to 12 months which was described as "statistically significant.""Ultimately, our goal was to highlight the emerging role of cancer neuroscience in GBM progression and emphasize the importance of exploring creative strategies to therapeutically target this evolving neural-tumor axis," lead author Joshua Bernstock, MD, PhD, a clinical fellow in the Department of Neurosurgery at Brigham and Women's Hospital, told Fox News Digital.BREAST CANCER DRUG COULD HELP PROLONG SURVIVAL FOR CHILDREN WITH BRAIN TUMORS, STUDY FINDSThe team was surprised by the survival benefit, Bernstock noted."Its always incredible to see a hypothesis come to life," he said. "I was also really pleased to see the decrease in serum TSP-1 levels in the UCSF cohort, potentially positioning it as a biomarker of response."Based on the initial findings, Bernstock reached out to researchers at the University of California, San Francisco (UCSF) to study more glioblastoma patients.Among the 379 patients at USCF, the same outcome was observed the ones who were taking gabapentin lived 20.8 months on average, compared to 14.7 months for those not taking the drug."Across both cohorts (1,072 patients total), gabapentin use was consistently associated with a statistically significant improvement in survival," Bernstock told Fox News Digital.The researchers also noticed that the gadapentin group had lower levels of a protein called TSP-1, which is found in the blood serum, a finding that "needs further investigation.""There have been very few advances in survival for GBM patients since the early 2000s," Bernstock said in the release. "We need to think more creatively about the emerging biology in these tumors and how to target them."The U.S. Food and Drug Administration (FDA) initially approved gadapentin in December 1993 to treat seizure activity in adults; the approval was extended to include children in 2000.Two years later, the agency approved gadapentin for nerve pain following shingles, according to the agency.The drug is often prescribed for off-label use to treat a range of pain conditions, studies show.Some of the more common side effects of gadapentin include fatigue, headache, dizziness, fever, nausea and vomiting, memory loss, trouble speaking, weight gain, vision problems, movement problems and recurring infections, according to Cleveland Clinic.Certain medications may interact with gadapentin. Patients should speak with a doctor if they experience severe or persistent side effects, experts recommend.The study did have some limitations, chiefly that it is retrospective and was not controlled."While the findings are promising, the study is retrospective patients were not given gabapentin in a controlled, randomized manner to directly assess its effects," Bernstock told Fox News Digital."As such, larger prospective clinical trials are needed to validate these results and to further investigate the role of gabapentin and TSP-1 in GBM progression."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERBernstock said he is "cautiously optimistic" by the findings."While gabapentin is FDA-approved and generally well-tolerated, it's not appropriate to change clinical practice based on these findings alone without a controlled study, something our collaborators at UCSF are working on," he said."That said, in GBM patients who develop neuropathic pain or seizures post-craniotomy, there may be a rationale to consider gabapentin more readily than other agents."For more Health articles, visitwww.foxnews.com/healthGlioblastoma described by Bernstock as "a relentlessly progressive and nearly universally fatal disease" is the most common type of primary brain cancer, according to Mayo Clinic.The disease claims the lives of around 14,500 Americans each year. The five-year survival rate is just 6.9%.

"Tick, tick, tick" is the sound "60 Minutes" viewers hear every Sunday evening on CBS. It's also the sound that journalists both inside and outside of CBS News continue to hear as the network's parent company Paramount Global mulls settling a multibillion-dollar lawsuit filed by President Donald Trump.Both Trump and Paramount have entered mediation, which could conclude at any time.Last October, Trump sued CBS News and Paramount for $10 billion over allegations of election interference involving the "60 Minutes" interview of then-Vice President Kamala Harris that aired weeks before the presidential election (the amount has since jumped to $20 billion).There have been reports that a settlement between $30-50 million could be reached, something Paramount hopes would clear the pathway towards its planned merger with Skydance Media, which seeks approval from Trump's FCC. Also fueling settlement rumors was Monday's abrupt resignation of CBS News CEO Wendy McMahon.CBS NEWS STAFFERS RATTLED BY CEO'S ABRUPT EXIT AS TRUMP LAWSUIT LOOMS OVER NETWORK"The unanimous view at 60 Minutes is that there should be no settlement, and no money paid, because the lawsuit is complete bulls---," one veteran "60 Minutes" producer told Fox News Digital.The CBS lawsuit stems from the "60 Minutes" primetime election special that aired last October featuring an interview with then-Vice President Kamala Harris, specifically an exchange Harris had with "60 Minutes" correspondent Bill Whitaker, who asked her why Israeli Prime Minister Benjamin Netanyahu wasn't "listening" to the Biden administration.Harris was widely mockedfor the "word salad" answer that aired in a preview clip of the interview on "Face the Nation." But when the same question aired during the primetime special, Harris had a different, more concise response. Critics at the time accused CBS News of editingHarris' "word salad" answerto shield the then-vice president from further backlash leading up to Election Day.PARAMOUNT FACING MOUNTING PRESSURE FROM CBS STARS, DEM LAWMAKERS AS COMPANY MULLS SETTLING TRUMP LAWSUITThe raw transcript and footage released earlier this year by the FCC showed that both sets of Harris' comments came from the same response, but CBS News had aired only the first half of her response in the "Face the Nation" preview clip and aired the second half during the primetime special.However, Trump has repeatedly asserted that CBS News took comments from a completely separate Harris response and inserted them in the exchange about Netanyahu.The veteran "60 Minutes" producer said scrutiny is always welcomed towards their work but called Trump's allegations against the program "absolute nonsense" and that there's "zero chance" his lawsuit would prevail in court."What he repeats over and over and the basis of his lawsuit is based on a falsehood," they said. "He keeps repeating it. But that doesn't make it true.""This is not being done in good faith. This is being done because people saw an opportunity to attack 60 Minutes and to attack CBS News," they added.CBS CORRESPONDENT SCOTT PELLEY HITS TRUMP FOR SUING JOURNALISTS FOR NOTHING IN FIERY COMMENCEMENT SPEECHThe prospects of an announced settlement in the coming days isn't out of reach. "60 Minutes" aired its final episode of the season this past Sunday and won't be airing new episodes until the fall, preventing someone like Scott Pelley from sounding off to viewers on the network drama like he did last month after the abrupt exit of "60 Minutes" executive producer Bill Owens, who left over increased interference by Paramount's controlling shareholder Shari Redstone, who reportedly favors settling the lawsuit."The act of his departure was a huge sacrifice," the veteran producer said of Owens. "I mean, this guy had the best job in television He chose to leave a great job because he sincerely wanted to save 60 Minutes."According to reports, Redstone wanted to "keep tabs" on upcoming "60 Minutes" segments involving Trump and urged CBS execs to delay any sensitive reporting on Trump until after the Skydance merger deal closed.A second "60 Minutes" producer told Fox News Digital that Redstone should "go read the history books.""Understand why a free and fair press is so key to this country and the way we run things and our democracy and our- everything. Go get a history lesson and quit looking at corporate mergers as what's the most important thing in the country," the second producer said. "Sometimes I feel like people are just so caught up in their silos, and she's so, you know, entrenched in this merger and getting the financial boom from a merger with Skydance that people forget why this is important.""Go talk to some journalists, go think about the times in history where a free press matters and made a difference Protect 60 Minutes. That's what she should be doing," they urged Redstone.Meanwhile, the first producer had a simple message for Redstone: "Don't settle. Don't appease the schoolyard bully."TRUMP, CBS PARENT COMPANY SET FOR MEDIATION IN $20 BILLION 60 MINUTES LAWSUITCBS News staff were rattled by the ousting of McMahon, who cited disagreements with the company in a memo to staff."It has been one of the most meaningful chapters in my career. Leading this extraordinary organization has been the honor of a lifetime because I got to work alongside all of you," McMahon wrote. "At the same time, the past few months have been challenging. Its become clear that the company and I do not agree on the path forward. Its time for me to move on and for this organization to move forward with new leadership."Paramount continues to face mounting pressure from critics in the media and Democratic lawmakers to CBS stars like Pelley and late-night host Stephen Colbert, who called out their parent company on the network's own airwaves.Representatives for CBS News, Paramount and Redstone did not immediately respond to Fox News Digital's requests for comment. President Trump's attorney also did not respond for comment.

Kevin Costner's parenting style is leading by example.While promoting his latest project, starring in the History Channel's new series "The West," Costner admitted he considered himself a "dumbbell" growing up, but he didn't let that stop him from chasing his passion, like American history and the West."I don't know, the advice thing, I'd like them to see how I do my work. I take it seriously. I'm a public school guy. I was often not at the wrong end of the bell curve. There was too much math, and there was not enough history. And I was made to feel like a dumbbell," Costner said."Because if you don't do well in that thing, you're a dumbbell. So, I always thought I was a daydreamer. I think I don't know what advice I give them, other than I hope they can find that yellow brick road, you know, to land on it and have the courage to go forward and don't let the economics drive their decisions in their lives. Find what they love," Costner said.YELLOWSTONE TO YOSEMITE: KEVIN COSTNER TELLS THE 'STRANGER THAN FICTION' STORY OF TAMING THE AMERICAN FRONTIERCostner is a father of seven. The "Yellowstone" star shares his oldest children Annie, 41, Lily, 38, and Joe, 37 with ex-wife Cindy Silva. He shares his son, Liam, 28, with ex-girlfriend Bridget Rooney.Costner and estranged wife Christine Baumgartner married in 2004 and welcomed three kids Cayden, 18, Hayes, 16, and Grace, 14. Baumgartner, a designer, filed for divorce from Costner in May 2023 after 18 years of marriage.During his interview with Fox News Digital, Costner teased that he gives in to his kids often, so he lets his dog Bob do the same."Bob just stands there with a dish in his mouth. He's like that. So, it's like I can deal with him. I can shame him," Costner said."I can't shame my kids who want the keys to the car. I can't shame them that their social schedule is more important than mine. They just rule me."LIKE WHAT YOURE READING? CLICK HERE FOR MORE ENTERTAINMENT NEWSCostner and Doris Kearns Goodwin serve as executive producers on "The West," and the actor is narrating the series.The History Channel show is eight parts and "provides a fresh look at the epic history of the American West by delving into the desperate struggle for the land itself and how it still shapes the America we know today," the website states.Goodwin told Fox News Digital she knew Costner would be perfect for this role due to his spiritual connection to the West, and his enthusiasm is "contagious" when you're around him.Costner told Fox News Digital he's a big fan of sports and compares the certainty of playing sports to the history of the West."I've always felt that I like sports, OK? I'm a sports guy. You and I know the score, right? There's nobody can bulls--- us about who won. There's something honest about the sports page. It's not dishonest. We find out who won, right? The rest of our news is a little bit nebulous, but sports never is.CLICK HERE TO SIGN UP FOR THE ENTERTAINMENT NEWSLETTER"And when we think about the West, if we think about it really honestly, we say it was a dangerous place. All the time, you had to be really resourceful. I know guys that kind of really want to see the truth. Let me see how raw it was. Let me how real it was. Am I that tough?" Costner said.Costner said living in the West was difficult, and history shows many people were forced to live there without the wherewithal to do so."They went in groups, and they sometimes perished as groups, and their humanity was alive. And their worst tendencies came out, and their best tendencies came out," he said.Costner's "The West" premieres on the History Channel Memorial Day and is available for streaming May 27.

As a former college football coach for 40 years, Ive witnessed firsthand the transformative power of college sports in shaping young lives. From the locker room to the classroom, athletics instill discipline, teamwork and resilience values that extend far beyond the field. But ever since the Supreme Court ruled that college athletes can be compensated for the use of their Name, Image and Likeness (NIL), college sports have been in a tailspin. While Im all for players making money, we need to create national standards to protect the integrity of college sports. Because there are no national rules for NIL contracts, every state has passed its own laws. This patchwork of laws has created an uneven playing field and given some universities advantages over their competitors. We now have pay-to-play as bidding wars for recruits are starting in middle and high school. This is not to mention the transfer portal, which has become a revolving door with student-athletes jumping from school to school in pursuit of more money. TRUMP CONSIDERING EXECUTIVE ORDER TO REGULATE NIL AFTER MEETING WITH NICK SABAN: REPORTFor example, the mens basketball teams at Kentucky, Duke and the University of North Carolina are preparing for their entire rosters to change in the upcoming 2025-26 season. This is not only bad for team culture, its also having negative impacts on the student-athletes educations, which is what college athletics is supposed to be all about. Ive been working to try to address these issues since I got to the Senate in 2021. Last Congress, West Virginia Independent Senator Joe Manchin and I introduced the "Protecting Athletes, Schools, and Sports Act" (PASS Act). This bipartisan legislation would establish a national standard for NIL contracts, ensuring consistency and fairness across all institutions. The PASS Act would also require universities to honor the original scholarship made to student-athletes, regardless of their NIL deal status, and provide stability by moderating eligibility for the transfer portal. CLICK HERE FOR MORE FOX NEWS OPINIONImportantly, this was not just our bill we worked with student athletes, coaches, athletics directors and parents to draft it. Unfortunately, Democrats, who had the majority at the time, refused to bring the bill to the floor for a vote. SEN TUBERVILLE PREVIEWS NIL MEETING WITH TRUMP, SAYS DEMOCRATS 'DON'T CARE' ABOUT COLLEGE SPORTSThankfully, President Donald Trumpa notorious sports fanis looking to get involved. A few weeks ago, I had the chance to talk to him about our fight to preserve college sports while on Air Force One headed to Tuscaloosa, Alabama. He was particularly focused on protecting womens and Olympic sports, which are sadly in danger of being eliminated at some schools who dont have enough money to play players. He was also focused on preserving education, ensuring antitrust protections are in place, and protecting womens and Olympic sports, which are sadly being eliminated at some schools that dont have enough money to pay players. In typical Trump fashion, he sprang into action. Following our conversation, the White House began exploring ways, ranging from an executive order to a federal commission, to address the most pressing issues within college athletics. By hearing from key stakeholders, including my friends former Coach Nick Saban from Alabama and former NFL player and Chairman of the Board of Regents of the Texas Tech University System Cody Campbell, the Trump administration is working to gather possible solutions that address the complexities of NIL and its impact on college sports. Regardless of which path Trump chooses to address the current state of college sports, Im confident that his administration which has already proven to be both effective and unafraid to shake up the status quo can make meaningful reforms to make sure college sports remain intact.NCAA POWER FOUR COMMISSIONERS SAY THEY 'NEED HELP FROM CONGRESS' TO REGULATE NIL, TRANSFER PORTALMeanwhile, Ill continue to work with my colleagues to hopefully draft legislation that could pass both chambers. The challenges facing college sports today are formidable, but not insurmountable. With President Trumps leadership and a unified approach, we can navigate this new era while preserving the integrity and spirit of collegiate athletics.CLICK HERE TO READ MORE FROM SEN. TOMMY TUBERVILLE

The Mexican Navy tall ship that crashed into the Brooklyn Bridge over the weekend did not issue any distress calls before the collision, but instead requested support, Mexico's Navy chief said.The Navy chief, Raymundo Morales, said on Tuesday that the port pilot maneuvering the Cuauhtmoc ship did not have much time to stop the vessel, as it had been docked a short distance from the bridge."We cannot speculate at this time whether the port pilot properly used all measures available," Morales said at a press conference with Mexican President Claudia Sheinbaum.BROOKLYN BRIDGE SUSTAINS NO STRUCTURAL DAMAGE AFTER FATAL MEXICAN NAVY SHIP CRASHTwo sailors were killed and more than 20 others were injured when the150-foot-tall Mexican Navy training ship struck the bridge around 8:30 p.m. Saturday. All those injured were aboard the ship, and none of the 277 people onboard fell into the water.Footage of the crash shows theship's three masts snapping after hitting the bridge. The footage also shows sailors clinging to the rigging ropes on the damaged masts.U.S. officials investigating the accident will examine a possible engine malfunction and the role of a tugboat that assisted the ship in backing out of its pier. The probe, officials said, will take at least 30 days."Of course, it will count on the collaboration and support of the Navy and the insurance company responsible for the ship," Sheinbaum said.Two cadets with severe injuries are receiving treatment at New York hospitals and their families have traveled there to be with them, Morales said."Their lives are not in danger and they will probably be released from the hospital on Wednesday," he said. "The two cadets that unfortunately died were transferred back to Mexico on Monday and their bodies are now with their families."CREW ON MEXICAN NAVY TALL SHIP SEEN CLINGING TO RIGGING AFTER COLLISION WITH BROOKLYN BRIDGE, VIDEO SHOWSCLICK HERE TO GET THE FOX NEWS APPThe Cuauhtmoc was built in Bilbao, Spain, in 1981 and has won the Tall Ships Races twice, according to Sail Training International. The ship was in New York City as part of a promotion for an event next year that celebrates Americas 250th birthday.Reuters contributed to this report.

Glioblastoma, the most aggressive and deadly type of brain cancer, is known to have a very poor prognosis but a new study suggests that a pain-relieving drug could extend survival.Researchers at Mass General Brigham have found that an already-approved medication a pain reliever and anti-seizure medication called gabapentin has been linked to improved survival in patients with glioblastoma.The findings were published in Nature Communications last week.MICHAEL BOLTON HAD STRANGE SYMPTOMS BEFORE BRAIN CANCER DIAGNOSIS: SOMETHINGS WRONGInspired by previous mouse studies that showed gadapentins potential in targeting tumors, the researchers studied the medical outcomes of nearly 700 patients with glioblastoma.Many of them had already been taking gabapentin to alleviate nerve pain, according to a press release from MGB.The patients who were taking the drug survived four months longer than those who were not 16 months compared to 12 months which was described as "statistically significant.""Ultimately, our goal was to highlight the emerging role of cancer neuroscience in GBM progression and emphasize the importance of exploring creative strategies to therapeutically target this evolving neural-tumor axis," lead author Joshua Bernstock, MD, PhD, a clinical fellow in the Department of Neurosurgery at Brigham and Women's Hospital, told Fox News Digital.BREAST CANCER DRUG COULD HELP PROLONG SURVIVAL FOR CHILDREN WITH BRAIN TUMORS, STUDY FINDSThe team was surprised by the survival benefit, Bernstock noted."Its always incredible to see a hypothesis come to life," he said. "I was also really pleased to see the decrease in serum TSP-1 levels in the UCSF cohort, potentially positioning it as a biomarker of response."Based on the initial findings, Bernstock reached out to researchers at the University of California, San Francisco (UCSF) to study more glioblastoma patients.Among the 379 patients at USCF, the same outcome was observed the ones who were taking gabapentin lived 20.8 months on average, compared to 14.7 months for those not taking the drug."Across both cohorts (1,072 patients total), gabapentin use was consistently associated with a statistically significant improvement in survival," Bernstock told Fox News Digital.The researchers also noticed that the gadapentin group had lower levels of a protein called TSP-1, which is found in the blood serum, a finding that "needs further investigation.""There have been very few advances in survival for GBM patients since the early 2000s," Bernstock said in the release. "We need to think more creatively about the emerging biology in these tumors and how to target them."The U.S. Food and Drug Administration (FDA) initially approved gadapentin in December 1993 to treat seizure activity in adults; the approval was extended to include children in 2000.Two years later, the agency approved gadapentin for nerve pain following shingles, according to the agency.The drug is often prescribed for off-label use to treat a range of pain conditions, studies show.Some of the more common side effects of gadapentin include fatigue, headache, dizziness, fever, nausea and vomiting, memory loss, trouble speaking, weight gain, vision problems, movement problems and recurring infections, according to Cleveland Clinic.Certain medications may interact with gadapentin. Patients should speak with a doctor if they experience severe or persistent side effects, experts recommend.The study did have some limitations, chiefly that it is retrospective and was not controlled."While the findings are promising, the study is retrospective patients were not given gabapentin in a controlled, randomized manner to directly assess its effects," Bernstock told Fox News Digital."As such, larger prospective clinical trials are needed to validate these results and to further investigate the role of gabapentin and TSP-1 in GBM progression."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERBernstock said he is "cautiously optimistic" by the findings."While gabapentin is FDA-approved and generally well-tolerated, it's not appropriate to change clinical practice based on these findings alone without a controlled study, something our collaborators at UCSF are working on," he said."That said, in GBM patients who develop neuropathic pain or seizures post-craniotomy, there may be a rationale to consider gabapentin more readily than other agents."For more Health articles, visitwww.foxnews.com/healthGlioblastoma described by Bernstock as "a relentlessly progressive and nearly universally fatal disease" is the most common type of primary brain cancer, according to Mayo Clinic.The disease claims the lives of around 14,500 Americans each year. The five-year survival rate is just 6.9%.

Trump, Budget Bill, Thrift Fashion